Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection

Current hepatitis C virus (HCV) treatment guidelines recommend treating HCV/human immunodeficiency virus (HIV)-coinfected individuals similar to HCV-monoinfected individuals. Recently inferior response rates to direct acting antiviral (DAA) therapy in HCV/HIV coinfection have been reported. Our Germ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Boesecke, Christoph, Ingiliz, Patrick, Berger, Florian, Lutz, Thomas, Schewe, Knud, Schulze zur Wiesch, Julian, Baumgarten, Axel, Christensen, Stefan, Rockstroh, Jürgen K, Mauss, Stefan
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5604144/
https://ncbi.nlm.nih.gov/pubmed/28948181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx158
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars